Company Filing History:
1 out of 1 
1 out of 4 Years Active: 2017
Title: Sangmi Kang - Innovator in Natural Killer Cell Production
Introduction
Sangmi Kang is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of natural killer (NK) cells. His innovative methods have the potential to enhance therapeutic approaches for treating cancers and infectious diseases.
Latest Patents
Sangmi Kang holds a patent titled "Method for producing natural killer cells, natural killer cells produced thereby, and composition for treating cancers and infectious diseases containing the same." This invention focuses on a method for producing NK cells that maintain high cytotoxicity and cell viability. The method allows for ex vivo culture at high efficiency and concentration, ensuring optimal conditions for the cells. Notably, the NK cells can be stored and supplied in liquid or frozen states without requiring additional treatment processes.
Career Highlights
Throughout his career, Sangmi Kang has worked with reputable organizations such as Green Cross Labcell and Mogam Biotechnology Institute. His experience in these companies has contributed to his expertise in cell production and biotechnology.
Collaborations
Sangmi Kang has collaborated with notable colleagues, including Bokyung Min and Hana Choi. Their joint efforts have likely advanced research and development in the field of natural killer cell applications.
Conclusion
Sangmi Kang's innovative work in the production of natural killer cells represents a significant advancement in biotechnology. His contributions have the potential to improve treatment options for various diseases, showcasing the importance of innovation in healthcare.